At its Aug. 19 meeting at Del Mar in Del Mar, Calif., the Racing Medication and Testing Consortium board approved a model rule for the regulation of bisphosphonates as well as further regulations and stacking prohibitions for non-steroidal anti-inflammatory drugs and intra-articular injections.
